Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hisamitsu Of Japan Bids For Control Of U.S.-Based Noven

This article was originally published in PharmAsia News

Executive Summary

Japan's Hisamitsu Pharmaceutical said it intends to bid for total control of Noven Pharmaceuticals of the United States at an estimated cost of $430 million. Hisamitsu already owns a 5 percent stake in the U.S. company. Noven focuses on drug-deliver patches, a fit for Hisamitsu since it specializes in pain-relieving patches. Hisamitsu President Hirotaka Nakatomi said the purchase also would speed the firm's expansion in the United States. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts